Thank you to all who attended our recent edition of the NIPC Series: New Frontiers in Heart Valve Disease on 4th Febraury.   We would like to extend our sincere gratitude to distinguished speakers Dr Darren Mylotter, Ms Sarah Early and our chair for the afternoon, Dr Sarah McErlean. We would also like to thank our sponsors Edwards, and you, the audience for making this such an engaging and interactive session.

If you missed this webinar, or would like to watch it again, you can now view the recording linked below, remember to log in or register to access.

About 1 in 40 adults in the general population are affected by Heart Valve Disease and this rises to over 1 in 10 in those over the age of 75 years. This growth is related to increasing expectancy and our ageing population resulting in degenerative conditions, such as Heart Valve Disease, becoming more frequent. Increased awareness and early detection of this condition can dramatically change disease progression.

In this recording, Dr Darren Mylotte highlights the importance of early detection and Ms Sarah Early provides an overview of new treatments and innovations in Heart Valve Disease. Watch the recording now. 

Agenda Included:

The Importance of Early Detection for Valve Disease

Dr Darren Mylotte

Consultant Cardiologist at Galway University Hospitals

New Treatments and Innovations in Valve Disease

Ms Sarah Early
Clinical Lead of Cardiothoracic Surgery at St. James’s Hospital; Consultant Cardiothoracic Surgeon at the Mater Private Hospital and Clinical Lecturer at Trinity College Dublin

Q&A Session

Chair: Dr Sarah McErlean
GP and Fellow, UCD and St Vincent’s Hospital

If you missed the last NIPC Series: Management and Treatment of Atrial Fibrillation, you can now catch the recorded session on-demand now. Log-In or Join the NIPC Alliance to view.

Subscribe to Our Newsletter